Literature DB >> 10680748

Serial changes in the galactosylation of autoantibodies and serum IgG in autoimmune haemolytic anaemia.

R N Barker1, K A Leader, C J Elson.   

Abstract

A number of systemic autoimmune diseases are associated with increased levels of the agalactosyl (G0) IgG isoforms that lack a terminal galactose from the C(H)2 domain oligosaccharide. The aims were to determine whether there are also persistently high levels of G0 autoantibodies or serum IgG in autoimmune haemolytic anaemia (AIHA), and whether any changes in galactosylation over time are related to the course of disease. Autoantibodies eluted from red blood cells, and serum IgG, were obtained from a patient with chronic AIHA over a 21 month period, and the degree of galactosylation measured using a lectin-binding assay. There were wide fluctuations in the galactosylation of autoantibody and serum IgG, but these changes were unrelated to the severity of the anaemia. The galactosylation of autoantibody and serum IgG varied independently, and the autoantibodies were preferentially G0 in comparison with serum IgG in only half of the serial samples. We conclude that AIHA differs from other, systemic autoimmune conditions in that high levels of G0 autoantibodies or serum IgG are not persistent, and that changes in galactosylation do not parallel the course of disease.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10680748     DOI: 10.3109/08916939908994053

Source DB:  PubMed          Journal:  Autoimmunity        ISSN: 0891-6934            Impact factor:   2.815


  3 in total

1.  Galactosylation of serum IgG and autoantibodies in murine models of autoimmune haemolytic anaemia.

Authors:  R N Barker; R D Young; K A Leader; C J Elson
Journal:  Clin Exp Immunol       Date:  1999-09       Impact factor: 4.330

2.  Structural studies on IgG oligosaccharides of patients with primary Sjögren's syndrome.

Authors:  Yasuhiro Kuroda; Munehiro Nakata; Ayako Makino; Ayano Matsumoto; Kazuhiro Ohashi; Koju Itahashi; Fujio Takeuchi; Makoto Goto; Naoya Kojima; Tsuguo Mizuochi
Journal:  Glycoconj J       Date:  2002-01       Impact factor: 2.916

3.  Patients with IgG1-anti-red blood cell autoantibodies show aberrant Fc-glycosylation.

Authors:  Myrthe E Sonneveld; Masja de Haas; Carolien Koeleman; Noortje de Haan; Sacha S Zeerleder; Peter C Ligthart; Manfred Wuhrer; C Ellen van der Schoot; Gestur Vidarsson
Journal:  Sci Rep       Date:  2017-08-15       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.